A Study to Evaluate the Experiences of Discrimination, Harassment, and Inclusion During Training and Climate Survey Development of Hematology/Oncology Fellows


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 18-001021
    Sponsor Protocol Number: 18-001021

About this study

The purpose of this study is to gain a detailed understanding of the current landscape of bias and/or discrimination involving hematology/oncology fellows at Mayo Clinic Rochester including the prevalence, source, and type of discrimination/harassment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • All hematology and oncology fellows (including advanced fellows) are eligible for the study.

Exclusion Criteria:

  • Hematology/oncology fellows no longer in training.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Katharine Price, M.D.

Contact us for the latest status

Contact information:

Rahma Warsame M.D.